The effect of weekly risedronate on periprosthetic bone resorption following total hip arthroplasty: a randomized, double-blind, placebo-controlled trial. [electronic resource]
Producer: 20111205Description: 1857-64 p. digitalISSN:- 1535-1386
- Absorptiometry, Photon
- Administration, Oral
- Adult
- Aged
- Analysis of Variance
- Arthroplasty, Replacement, Hip -- adverse effects
- Bone Density -- drug effects
- Bone Density Conservation Agents -- administration & dosage
- Bone Resorption -- drug therapy
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Etidronic Acid -- administration & dosage
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Periprosthetic Fractures -- prevention & control
- Postoperative Complications -- prevention & control
- Reference Values
- Risedronic Acid
- Risk Assessment
- Sweden
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.